Glen Harbor Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Glen Harbor Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$179K	Buy	21,532 +588	+3%	+$4.76K	﹤0.01%	1050
2019 Q2	$180K	Buy	20,944 +2,772	+15%	+$24.8K	﹤0.01%	1045
2019 Q1	$194K	Hold	18,172	–	–	﹤0.01%	1002
2018 Q4	$159K	Buy	18,172 +3,052	+20%	+$38.9K	﹤0.01%	1009
2018 Q3	$254K	Buy	15,120 +1,316	+10%	+$28.5K	0.01%	974
2018 Q2	$289K	Hold	13,804	–	–	0.01%	851
2018 Q1	$222K	Buy	13,804 +1,400	+11%	+$27.7K	0.01%	932
2017 Q4	$235K	Buy	12,404 +6,524	+111%	+$118K	0.01%	919
2017 Q3	$83K	Buy	+5,880	New	+$53.2K	﹤0.01%	1150

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glen Harbor Capital Management's SPPI Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Spectrum Pharmaceuticals Inc (SPPI) stake by 2.8% in Q3 2019, buying an estimated $4.76K and bringing the position to 21,532 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #1050.

Glen Harbor Capital Management first reported a position in SPPI in Q3 2017 and has held it in 9 quarters since. The position peaked at $289K in Q2 2018. 167 funds tracked by Wall St. Rank hold SPPI as of Q3 2019.

Glen Harbor Capital Management held 21,532 shares of Spectrum Pharmaceuticals Inc worth $179K as of Q3 2019.
Glen Harbor Capital Management bought 588 Spectrum Pharmaceuticals Inc shares in Q3 2019, an estimated $4.76K.
Spectrum Pharmaceuticals Inc made up ﹤0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #1050 holding.
Glen Harbor Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2017 and has held it in 9 quarters since.
Glen Harbor Capital Management's Spectrum Pharmaceuticals Inc position peaked at $289K in Q2 2018.
167 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.